Description
Tildren (tiludronate) has been used for a number of years by veterinarians in Europe to treat joint conditions such as navicular disease and bone spavin. It works by regulating bone remodelling in cases where there is too much bone resorption.
Administered as a slow intravenous infusion by a veterinary surgeon.
Warnings & Contraindications
This product is contraindicated in horses less than 3 years old and in those with impaired renal function. The product should not be administered in cases of known hypersensitivity to bisphosphonates or to any of the excipients. Avoid self-injection; if it occurs, seek medical attention.
Pregnancy & Lactation
It should not be used in pregnant or lactating mares, as its safety with them has not been studied.
For further product information please click on the link below. This will take you to the Veterinary medicines directorate (VMD) website where you can search for the product and see the most up to date Summary of product characteristics (SPC).
